MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa…
Recalled by Wisconsin Pharmacal Company
Drug recall
Wisconsin Pharmacal Company
Class I — most serious
There is a reasonable chance that using this product could cause serious health problems or death.
Wisconsin Pharmacal Company has recalled MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa…, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on May 27, 2026 and was initiated on April 24, 2026. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa…, with approximately 690 tubes affected. The company behind the recall is Wisconsin Pharmacal Company, based in Jackson, WI. The FDA describes the product as: “MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.”
Why was MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa… recalled?
According to the FDA, the stated reason for the recall is: “Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.” In plain terms, this recall relates to a sterility or contamination concern.
Sterile medicines, such as injectables and eye drops, must be completely free of microorganisms and stray particles. This recall means that sterility could not be assured or that contamination was found or suspected. Using a non-sterile product of this kind can cause infections, which is why these recalls are treated seriously.
What should you do?
If you think you may have bought MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa…, compare it against the product description and identifying codes (Lot #: 1024088, Exp 11/30/2026) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Wisconsin Pharmacal Company or your local health authority.
About this recall
This recall was distributed in WI. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- May 27, 2026
- Recall started
- April 24, 2026
- Distributed in
- WI
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa… recalled?+
According to the FDA: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
How serious is this recall?+
Class I — most serious. There is a reasonable chance that using this product could cause serious health problems or death.
What should I do if I have MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oa…?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0553-2026. Information last synced from the FDA on July 5, 2026.